René dePont Christensen

statistiker, ph.d.

20022019
Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2002 2019

Filtrer
Poster
2018
2017

PATIENT-INITIATED FOLLOW-UP AFFECTS FEAR OF RECURRENCE AND HEALTH CARE USE – RESULTS FROM THE OPAL TRIAL

Jeppesen, M. M., Jensen, P. T., Hansen, D. G., Christensen, R. D. & Mogensen, O., 2017.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2015

Predictive value of gynecological cancer alarm symptoms in a general population

Balasubramaniam, K., Ravn, P., Christensen, R. D., Søndergaard, J. & Jarbøl, D. E., 20. maj 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2014
481 Downloads (Pure)

Influence of Productivity on the Acquisition of Inflectional Markers

Kjærbæk, L., Basbøll, H. & Christensen, R. D., 15. jul. 2014.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang
Fil

Primary Surgery or Interval Debulking for Advanced epithelial ovarian cancer

Markauskas, A., Mogensen, O., Christensen, R. D. & Jensen, P. T., 2014.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2013

Associations between patients' concerns about medicines and generic substitution: a cross sectional questionnaire and register study

Østergaard Rathe, J., Søndergaard, J., Christensen, R. D., Jarbøl, D. E. & Andersen, M., 2013.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Development of a web-based patient questionnaire for needs assessment of cancer patients in a primary care setting

Veloso, A. G., Thayssen, S., Christensen, R. D., Søndergaard, J., Thomsen, J. L. & Gilså Hansen, D., aug. 2013.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Measures of “exposure needed for one additional patient to be harmed”

Hallas, J., Christensen, R. D., Stürmer, T. & Pottegård, A., 2013.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

The prognostic importance of miRNA-21 in stage II colon cancer. A population based study

Kjær-Frifeldt, S., Hansen, T. F., Nielsen, B. S., Lindebjerg, J., Christensen, R. D., Sørensen, F. B. & Jakobsen, A., 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2008

A Nordic Society of Gynecological Oncology (NSGO) multicenter, non-randomized, phase II study of docetaxel and carboplatin as second-line chemotherapy in patients with first elapse of platinum-sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Baekelandt, M., Herrstedt, J., Christensen, R. D., Kærn, J., Lund, B., Mirza, M. R., Jensen, T. S., Maenpaa, J., Madsen, E. L. & Kristensen, G. B., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

2006

Pegylated liposomal doxorubicin (PLD) and gemcitabine (GEM) in combination in the salvage treatment of epithelial ovarian cancer

Mirza, M. R., Lund, B., Bertelsen, K., Lindegaard, J., Keldsen, N., Mellemgaard, A. & Christensen, R. D., 2006.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Reproducibility of Protein Profiling by Solid Phase Extraction and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry

Callesen, A. K., Madsen, J. S., Jørgensen, P. E., Kruse, T., Cold, S., Mogensen, O., Vach, W., Christensen, R. D., Tan, Q. & Jensen, O. N., 2006.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning